The ATLANTA First in Man Study of the Catania Stent
NCT00799032
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
55
Enrollment
INDUSTRY
Sponsor class
Conditions
Coronary Artery Disease
Interventions
DEVICE:
PCI
Sponsor
CeloNova BioSciences, Inc.